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ABSTRACT
The functional consequences of selectively lesioning
the lateral olivocochlear efferent system in guinea
pigs were studied. The lateral superior olive (LSO)
contains the cell bodies of lateral olivocochlear neu-
rons. Melittin, a cytotoxic chemical, was injected into
the brain stem using stereotaxic coordinates and
near-field evoked potentials to target the LSO. Brain
stem histology revealed discrete damage to the LSO
following the injections. Functional consequences of
this damage were reflected in depressed amplitude of
the compound action potential of the eighth nerve
(CAP) following the lesion. Threshold sensitivity and
N1 latencies were relatively unchanged. Onset adap-
tation of the cubic distortion product otoacoustic
emission (DPOAE) was evident, suggesting a reason-
ably intact medial efferent system. The present results
provide the first report of functional changes induced
by isolated manipulation of the lateral efferent
pathway. They also confirm the suggestion that
changes in single-unit auditory nerve activity after
cutting the olivocochlear bundle are probably a
consequence of disrupting the more lateral of the two
olivocochlear efferent pathways.
Keywords: lateral superior olive, guinea pig, oli-
vocochlear, compound action potential, distortion
product otoacoustic emission
INTRODUCTION
The lateral and medial olivocochlear efferent systems
can be distinguished using a number of criteria.
These differences have been previously described and
are reviewed here only briefly. First, the medial ef-
ferent pathway originates in medial, ventral, or peri-
olivary zones (depending on the species), whereas
the lateral efferent pathway originates in, or near, the
lateral superior olive (LSO: for reviews, see Warr et al.
1986; Warr 1992). Second, whereas the medial effer-
ent pathway is primarily a crossed system (approxi-
mately 60%–70% of the neurons cross the brain stem
and innervate the ear contralateral to the site of ori-
gin), the lateral efferent pathway is predominantly
uncrossed (for reviews, see Warr et al. 1986; Warr
1992). Third, the medial efferent neurons that pro-
ject to the cochlea and synapse on the outer hair cells
(OHCs) immunolabel positively for acetylcholine
(ACh) and c-aminobutyric acid (GABA; for reviews,
see Eybalin 1993; Puel 1995; Le Prell et al. 2001). In
contrast, the lateral efferent neurons synapse on the
dendrites of the auditory nerve and, to a much lesser
extent, the inner hair cells (IHCs). Immunocyto-
chemical evidence suggests lateral efferent neurons
contain a variety of neuroactive substances, including
ACh, GABA, dopamine (DA), dynorphin (dyn),
enkaphalin (enk), and calcitonin-gene-related pep-
tide (CGRP; for reviews, see Eybalin 1993; Puel 1995;
Le Prell et al. 2001).
Given anatomical and neurochemical differences,
functional distinction of the lateral and medial ef-
ferent pathways would also be expected. However, a
precise identification of lateral efferent function has
not yet been possible. This is largely because surgical
cuts of the efferent pathways disrupt only the crossed
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portion of the medial efferent pathway or both the
medial and lateral pathways (e.g., Liberman 1991;
Kujawa and Liberman 1997). Electrical stimulation
paradigms, in which medial olivocochlear (MOC)
neurons are electrically stimulated by an electrode
placed at the floor of the fourth ventricle (e.g., Rajan
1988; Liberman 1991) or by an electrode near the site
of MOC origin (i.e., Gifford and Guinan 1987), acti-
vate only portions of the medial efferent neurons.
Pharmacological manipulations initially appear to
be useful in distinguishing lateral and medial efferent
pathways. The glycinergic antagonist strychnine has
been used to chemically block medial efferent func-
tion (e.g., Desmedt and Monaco 1961; Bobbin and
Konishi 1974; Sridhar et al. 1995; Dolan et al. 1999).
Recent molecular characterizations suggest that me-
dial efferent modulation of OHC function occurs at
heteromeric receptors composed of both a9 and a10
subunits (Elgoyhen et al. 2001). The distribution of
a9 (and a10) receptors suggests the effects of
strychnine will be limited to MOC blockade. Strych-
nine is also a potent antagonist at cholinergic a7 re-
ceptors isolated from retinal (Gotti et al. 1997) and
hippocampal (Albuquerque et al. 1998; Matsubayashi
et al. 1998) tissues; however, and the a7 receptor has
been localized to type I spiral ganglion cells (Morley
et al. 1998). Given that the predominant target for
the LOC neurons is the type I spiral ganglion neu-
rons, intracochlear strychnine may disrupt lateral ef-
ferent function. The functional significance of a
potential strychnine blockade at a9 receptor subunits
at the base of the IHCs (Elgoyhen et al. 1994; Park et
al. 1997; Morley et al. 1998) is unclear.
In the present study we selectively destroyed neu-
rons of the lateral olivocochlear system by injecting
melittin into the LSO. Melittin is a cytotoxic extract
of bee venom that disrupts the lipid bilayers of cells,
thus altering cell membrane permeability and leading
to intracellular ionic imbalance and cell death (Be-
chinger 1997; Kourie and Shorthouse 2000). The
injection technique was modeled after a procedure
that lesions the superior olivary complex (SOC) via
injection of kainic acid (KA) into the brain stem.
Those experiments were conducted in guinea pigs
(Gardi and Bledsoe 1981; Bledsoe et al. 1990), rats
(e.g., Li and Kelly 1992; Sally and Kelly 1992), ferrets
(Rooney et al. 1991), and cats (Zaaroor and Starr
1991). One drawback to experiments in which KA is
used to lesion the brain stem is that KA injection
produces broad damage. Melittin offers an advantage
over KA in that injection of melittin produces a dis-
crete and well-localized lesion.
The LSO is the predominant nucleus of origin for
the lateral efferent pathway in the guinea pig (Strutz
and Bielenberg 1984; Robertson 1985; Aschoff and
Ostwald 1987; Stopp 1990). In support of these
findings, lesioning the LSO resulted in selective de-
generation of the lateral efferent innervation of the
cochlea as demonstrated by reduced labeling of syn-
aptic vesicles in cochlear tissues that were immuno-
labeled with synaptophysin. The primary functional
effect of lesioning the LSO was a reduction in CAP
amplitude. This result supports and extends previous
suggestions that the lateral efferent innervation of the
cochlea modulates auditory nerve activity (Liberman
1990; Zheng et al. 1999).
METHODS
Subjects
Female guinea pigs (Elm Hill Breeding Labs,
Chelmsford, MA) were used in these experiments. A
number of animals were excluded based on elevation
of thresholds prior to any experimental manipula-
tion, evidence of middle ear infection at the time of
euthanasia, or because the extent of damage to the
LSO could not be assessed as portions of the SOC
were missing. Only one animal died during recovery
from the surgical brain stem lesion procedure. The
remaining animals composed an acute electrophysi-
ology group (N = 14) and a chronic electrophysiology
group (N = 3). All animals underwent electrophysio-
logical assessment of auditory function by measuring
input–output functions for the sound-evoked whole-
nerve compound action potential (CAP) response.
Animals in the acute electrophysiology experi-
ments underwent CAP testing 7 days after a lesion of
the LSO (N = 4); control animals included animals
that were not lesioned (N = 9) and an animal in
which the lesion missed the LSO (N = 1). Data from 5
additional animals were excluded based on the cri-
teria described above. For acute CAP recordings, a
silver-wire ball electrode was placed on the round
window from a postauricular surgical approach.
In the chronic electrophysiology experiments,
guinea pigs were implanted with indwelling plati-
num–iridium ball electrodes that rested on the round
window membrane. Beyond the second day postim-
plant, there was no evidence of time-related changes
in CAP measures. These animals were allowed to re-
cover for approximately one week, during which time
baseline CAP measures were collected, and then the
animals were lesioned. The melittin injections pro-
duced either targeted disruption of LSO (N = 3; an-
imals hereafter identified as ‘‘HIT1,’’ ‘‘HIT2,’’ and
‘‘HIT3’’) or no damage to the LSO (N = 1; animal
hereafter identified as ‘‘MISS1’’). We were unable to
identify any damage within the auditory nuclei of
animal MISS1, thus, we suspect the injection failed to
deliver melittin into the neural tissue. We note that
data from HIT3 were excluded based on evidence of
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an active middle ear infection at the time of eutha-
nasia, and data from a fifth animal were excluded
because portions of the SOC were missing.
All animals were maintained with free access to
food (Purina guinea pig chow) and water. The animal
care program was AALAC accredited. Husbandry met
or exceeded all applicable standards, including the
Guide for the Use and Care of Laboratory Animals, pre-
pared by the National Research Council (1996). The
Institutional Animal Care and Use Committee of the
University of Michigan approved all animal care and
testing protocols.
Apparatus and procedures
Brain stem lesions. Guinea pigs (250–350 g) were a-
nesthetized (108 mg/kg ketamine, 14 mg/kg xyla-
zine) and positioned in a Kopf (Model 1404)
stereotaxic head holder (David Kopf Instruments,
Tujunga, CA). The surface of the head was cleansed,
and, using aseptic technique, the skull was surgically
exposed and then thinned with a dental drill between
Bregma and Lambda from approximately 1 mm left
of midline to 3 mm right of midline. The thinned
skull was removed using small bone rongeurs, ex-
posing the midline blood vessels and the transverse
sinus.
A pulled glass pipette (tip diameter approximately
20–50 lm) was affixed to a 1.0 ll glass microsyringe
(model No. 700; Hamilton Company, Reno, NV).
The syringe and tip were filled with melittin (Sigma
Chemical St. Louis, MO). Prior to use, melittin was
dissolved in normal Ringer solution (145 mM NaCl,
2.7 mM KCl, 2.0 mM MgSO4, 1.2 mM CaCl2, and 5.0
mM HEPES; pH 7.40; osmolality = 280–285 mOsm)
for a final concentration of 10 mM melittin in solu-
tion (pH 7.0+0.5; osmolality = 419 mOsm). The so-
lution was aliquotted for storage at 0C and warmed
to room temperature prior to filling the microsy-
ringe. Once filled with melittin, the microsyringe was
positioned 1.2 mm posterior to the center of the au-
ditory meatus (measured posterior to the center of
the fixed earbar position), and 2 mm right of mid-
line, at a 4 (forward) angle off of vertical. The sy-
ringe, which was also used for evoked potential
assessment as described by Gardi and Bledsoe (1981),
was lowered through the cerebellum into the brain
stem to an initial depth of 8 mm.
Near-field sound-evoked potentials were assessed
for right ear, left ear, and binaural stimulation at 8
mm, and at depths proceeding in 0.5 mm increments.
At each electrode depth, 10 kHz tone pips (0.5 ms
rise–fall time; 70 dB-SPL) were used to generate
neural responses. Acoustic stimuli were delivered via
a 200 W Beyer transducer (part number 102.938, type
B4-31.05-00) housed in a custom-designed shielded
case and tightly connected to hollow ear bars at-
tached to the stereotaxic device. Sound pressure level
calibrations were specific to each ear bar and were
based on stimulus levels measured using a micro-
phone (Bruel & Kjaer type 4136 microphone, type
2619 preamp, type 2804 power supply) that was cou-
pled to the ear bar at a distance of approximately 1
mm. Coupling of the ear bar to the microphone
during acoustic stimulus calibration was via vinyl
tubing selected to approximate the guinea pig ear
canal.
Acoustic stimuli were generated using Tucker–
Davis Technology (TDT) System II/System III hard-
ware and SigGen 3.2 software (Tucker–Davis Tech-
nology, Alachua, FL). Evoked potentials were filtered
(300–3000 Hz) and amplified (1000·) using locally
constructed equipment and then digitized using the
TDT BioSig 3.2 software package. BioSig 3.2 software
was used to generate averaged evoked responses fol-
lowing 5 stimulus presentations (2/s). The depth of
the LSO was identified by the maximum evoked re-
sponse. In addition, the binaural interaction compo-
nent was evaluated to determine when the sum of
right ear or left ear stimulation was different than the
effect of binaural stimulation (see Finlayson and
Caspary 1989; Wada and Starr 1989; Ungan and
Yagcioglu 2002).
Using the evoked potentials as a guide, injections
of 10 mM melittin (0.2 ll) were made at depths
ranging from 9 to 9.5 mm. Melittin was injected via
manually applied pressure delivered over a 1-min
period. Following the injection of the cytotoxin,
evoked potentials were reassessed. Approximately 2
min later, the syringe was removed from the brain
stem, the skull was covered with Durelon carboxylate
cement (ESPE, Seefeld, Germany), and the skin was
sutured. Warmed saline (38C, 20 ml/kg) was in-
jected subcutaneously at the conclusion of the surgi-
cal procedure. In addition, animals were treated with
the antibiotic chloramphenicol (30 mg/kg, twice
daily) to prevent postoperative infections.
Inner ear electrophysiology—acute procedure. Ani-
mals were anesthetized (108 mg/kg ketamine, 14
mg/kg xylazine), screened for healthy tympanic
membranes and ear canals, and placed in a guinea
pig head holder (SG-1, Narishige Group, East Mead-
ow, NY). A thermostatically controlled heating pad
was used to maintain body temperature at 37–38C. A
right postauricular incision was made, and the bulla
was carefully exposed and opened. A silver-wire ball
electrode (diameter = 0.3–0.35 mm) was placed gen-
tly on the round window and cemented in place.
Acoustic stimuli were delivered from the Beyer
transducer, which was tightly connected to hollow ear
bars that were fixed to the Narishige head holder. CAP
input–output functions were determined for brief
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pure-tone stimuli (2–20 kHz; 2 kHz increments) pre-
sented at levels ranging from 0 to 100 dB SPL (5 ms
tone pips, 0.5 ms rise–fall; 10/s). Acoustic stimuli were
generated using TDT System II/System III hardware
and SigGen 3.2 software. Stimulus calibrations specific
to the ear bars that fit the Narishige head holder were
conducted as described above. Evoked potentials were
filtered (300–3000 Hz) and amplified (1000·) using
locally constructed equipment. BioSig 3.2 software was
used to average 25 presentations within each fre-
quency/level combination. Responses to 20 kHz 100
dBSPL stimuli were discarded because of substantial
distortion of the acoustic signal.
Inner ear electrophysiology—chronic procedure. Ani-
mals were anesthetized (108 mg/kg ketamine, 14
mg/kg xylazine), screened for tympanic membrane
inflammation, positioned in the Narishigi head
holder, and placed on a heating pad to maintain
body temperature at 37–38C. Aseptic surgical pro-
cedures were used. From a right postauricular ap-
proach, the bulla was carefully exposed and opened
and a platinum–iridium wire ball electrode (0.3–0.35
mm diameter) was placed gently on the round win-
dow and cemented in place at the bulla opening. The
free end of the electrode, which had been soldered to
a pin-based socket strip connector (Samtec Inc., New
Albany, IN) and sterilized prior to the implant sur-
gery, was cemented to the top of the skull using Jet
Repair Acrylic (Lang Dental Manufacturing, Wheel-
ing, IL). A ground wire was implanted into the mus-
cles of the neck. Use of this two-pronged connector
allowed CAP responses to be assessed within the same
animal over long periods of time, including prelesion
and postlesion.
Following the implant surgery, CAP responses were
assessed. Acoustic stimuli were generated as de-
scribed above. However, sounds were presented
through a piece of plastic tubing inserted into the ear
canal. Use of this tubing avoided trauma to the ear
canal as a result of repeated placement into the head-
positioning device. CAP input–output functions were
determined in anesthetized animals as described
above; however, for a subset of animals, testing was
limited to 10 kHz. Stimulus calibrations specific to
the plastic tubing were used during collection and
summary of the data. Following injection of melittin
into the brain stem, electrophysiological testing was
conducted at various time points, including immedi-
ately, 1-day, and 1-week post lesion, as well as at
weekly intervals extending to 17 weeks postlesion.
DPOAE testing. The lesioned animals in the
chronic experiments underwent DPOAE testing at 1
and 9-weeks postlesion. The cubic distortion product
was assessed. Testing was conducted in the contra-
lateral ear as a control procedure, unless the tym-
panic membrane of the contralateral ear appeared
cloudy, red, or otherwise irritated. A MatLab program
was used to control stimulus generation (TDT hard-
ware) and data collection. Two Beyer transducers
were used to generate acoustic signals. Transducer
output was tightly coupled to sound delivery ports in
the microphone used to measure sound-evoked
DPOAEs (Etymotic Research, Elk Grove Village, IL;
ER-10B+ Low Noise Microphone). The microphone
(gain = 40 dB) was covered with an open-ended
plastic tip to shield it from any wax in the ear canal
and was placed inside the ear of the anesthetized
animal using a microscope. The shielded micro-
phone was placed near the tympanic membrane,
which was inspected for inflammation or trauma be-
fore and after each DPOAE procedure.
During DPOAE testing, the primary tones were
fixed at 8 kHz (F1) and 9.6 kHz (F2). Initially, F1 and
F2 levels were 60-dB SPL; sound levels were adjusted
until the cubic distortion product (2F1 ) F2) was 10–
15 dB above the noise floor. The level of F2 was
then systematically decreased until it was 10 dB lower
than that of F1. The level of F2 was increased to equal
the level of Fl (as a test/retest control procedure), and
then the level of Fl was decreased until it was 10 dB
lower than that of F2. The level of Fl was increased to
equal the level of F2 at the conclusion of the DPOAE
testing. Responses to 25 stimulus presentations were
collected and averaged at each sound level combina-
tion (50 ms duration, presentation rate = 1/s).
Brain stem histology. At the conclusion of electro-
physiological testing, most animals were anesthetized
and euthanized via intracardiac perfusion of fixative
[4% paraformaldehyde, or 3% glutaraldehyde + 2%
paraformaldehyde, in phosphate buffer (PO4: 0.1
M)]. The brain stem was removed and placed in 4%
paraformaldehyde for a minimum of 24 h. The brain
was then placed in a 30% sucrose solution for 24–48
h, sectioned (70 lm) using a freezing microtome,
mounted on glass slides, and stained with cresyl vio-
let. We note that the placement of the pipette in the
brain stem transected the OCB in one guinea pig that
was not included in this investigation. Because cresyl
violet stain does not readily allow an evaluation of
OCB integrity, processing of neural tissues was dif-
ferent for two animals (HIT2 and MISS1). Brain stem
sections from these animals were labeled for acetyl-
cholinesterase following Osen and Roth (1969; see
also Liberman 1990). The animals were anesthetized
and euthanized via intra cardiac perfusion of 10%
formalin solution. The brains were removed, placed
in 10% formalin solution overnight, and stored in
PBS. The brains were later placed in a 5% sucrose
solution for 3 days and then sectioned (80 lm) using
a freezing microtome.
All sections were viewed under a Leitz Laborlux
Microscope, digitized using a Nikon Coolpix 990
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digital camera, and analyzed using Metamorph
Imaging System (4.5a5, Universal Imaging Corpora-
tion, Downingtown, PA). Following treatment with
cresyl violet label, the lesion appeared as a darkened
area where glia and scar tissue invaded the healthy
cell region (see Fig. 1). In contrast, in sections treated
with acetylcholinesterase histochemistry, the lesion
appeared as a loss of the brown neuropil staining.
Brain stem sections were scored as hits when the lat-
eral limb of LSO was completely disrupted and at
least some portion of the medial limb was also dam-
aged. When LSO was hit, the area of the undamaged
cell bodies within LSO was measured on both sides of
the brain stem (see Fig. 2). To measure undamaged
area, regions containing intact cell bodies were cir-
cled and the area of the circle was calculated using
Metamorph image analysis software.
Inner ear histology. After removal of the brain, the
temporal bones were removed. They were dissected
open at the round window and the apex and gently
perfused with 4% paraformaldehyde in phosphate
buffer (PO4: 0.1 M). Immunolabeling with antisyn-
aptophysin mouse monoclonal antibody (1:10 dilu-
tion; IGN Pharmaceuticals, Inc., Aurora, OH) was
conducted using procedures modeled after those of
Burgess et al. (1997). The tissues were then carefully
dissected for surface preparations and mounted on
glass slides or were dehydrated in graded alcohols
and embedded in resin (Embed 812; Electron Micr-
oscopy Sciences). Synapse-specific labeling was ob-
served in cochlear tissues from two animals that were
perfused with 4% paraformaldehyde (see Fig. 3).
Tissues from one animal were limited to the basal
turn due to trauma associated with dissection; tissues
from the second animal were available for all cochlear
turns.
Lateral efferent innervation of the cochlea is not
easily quantified because lateral efferents appear as
distinct puncta that range in size as well as amor-
phous bundles. Given that they cannot be readily
counted, we quantified lateral efferent innervation by
determining the surface area of the immunolabeled
lateral efferents in the intact ear and in the ear for
which lateral efferent innervation was expected to be
disrupted (i.e., the ear ipsilateral to the brain stem
lesion). Surface area was assessed across a 325 lm
segment from each cochlear turn in four sections of
approximately 81 lm. Labeled area was measured
using a sliding analysis window (area = 974 lm2) and
fixed color/intensity exclusion criterion within
Metamorph. Labeling within each of the four sections
was averaged for a final estimate of labeling within
each cochlear turn (see Fig. 4). To verify that use of a
fixed criterion did not bias the final result, we also
evaluated immunolabeled area using a variable
threshold criterion that included only discrete, darkly
stained puncta, and a criterion in which threshold
was adjusted until all immunolabeled area was in-
cluded. Immunolabeled area varied with the applied
criterion (i.e., labeled area was greatest when all im-
munolabeled area was included), but there were no
systematic differences in the pattern of results. Be-
cause there was nonspecific labeling of the remaining
gluteraldehyde-fixed tissues, lesion success was veri-
fied using brain stem analyses in animals with tissues
that were fixed with gluteraldehyde.
RESULTS
Anatomy
Brain stem quantification. The area of LSO that was
undamaged (i.e., intact cell bodies were evident) on
FIG. 1. Representative brain stem section from an acute test animal
scored as an LSO hit. Left: Intact (control) side of brain stem. Both
the U-shaped lateral superior olive (LSO) and the more medially
located medial superior olive (MSO) are evident (see labeled ar-
rows). Right: The experimental (cytotoxin-injected) side of the same
brain stem as depicted in left panel. The lesion is centered over the
LSO, with only the most ventromedial aspects of LSO appearing
undamaged. The damage to the neural tissue does not extend to the
MSO. Scale bar = 400 lm.
FIG. 2. Area of intact (undamaged) lateral superior olive (LSO) was
measured following injection of a cytotoxin into the vicinity of LSO
(e.g., ‘‘Lesioned’’). Control comparisons were provided from meas-
urements of LSO area in contralateral, uninjected LSO (e.g., ‘‘Un-
lesioned’’). Section 1 was the most caudal section in which LSO
appeared. Sections were sequentially numbered until LSO was no
longer evident. Asterisks denote statistically reliable differences be-
tween lesioned and unlesioned sections (p’s < 0.05).
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the lesioned side and the area of the entire LSO on
the side of the brain stem contralateral to the injec-
tion were measured in all cresyl violet-labeled sections
(e.g., Fig. 1). For the acute test animals, which were
all sacrificed 1 week postlesion, measurements of in-
tact LSO area were compared using a two-way analysis
of variance (ANOVA), with section number and
group (control versus lesion) as independent varia-
bles. SigmaStat software (version 2.01) was used for
all two-way ANOVAs.
The intact area of LSO was significantly smaller in
lesioned LSO sections than in contralateral control
LSO sections (F = 21.831, df = l, 44, p < 0.001). Re-
sults of pairwise comparisons, conducted using the
Student–Neuman–Keuls method, are shown in Figure
2. The lesions were clearly centered toward the caudal
end of LSO. At its rostralmost point, there was no
difference between lesioned and control LSO sec-
tions. Along the medial–lateral dimension, the le-
sions were consistently placed in the lateral limb of
the LSO. Lesions of the lateral limb extended fairly
broadly along the rostral–caudal dimension; lesions
of the medial limb of the LSO were restricted to a
subset of brain stem sections for each animal.
Immunolabeling of cochlear tissues. Evaluation of
synaptophysin immunolabeling was possible in tissues
fixed without gluteraldehyde. Tissues from two ani-
mals that were euthanized 1 week postlesion were
prepared using this protocol; representative sections
are depicted in Figure 3. Synaptophysin immuno-
labeling was quantified for the animal from which all
cochlear turns were available. With the exception of
tissues taken from the second turn of the cochlea,
synaptophysin immunolabeling of lateral efferent
synaptic vesicles was reduced, but not eliminated, in
the cochlea ipsilateral to the site of the lesion (i.e.,
the cochlea receiving lateral efferent projections
originating at the site of the lesion). This result is
illustrated in Figure 4. That there was a greater re-
duction in synaptophysin immunolabeling in the
lower-frequency apical turns of the cochlea is con-
sistent with the observation that lesions disrupted the
lower-frequency lateral limb of the LSO more than
the higher-frequency medial limb of the LSO. The
lack of disruption to immunolabeling in the second
turn may correspond to the ventromedial region of
FIG. 3. Cochlear tissues were immunolabeled with antisynapto-
physin to indicate the density of efferent terminals. Tissues from the
cochlea contralateral to the injection site (i.e., the control cochlea
receiving intact lateral efferent projections from the unlesioned side
of the brain stem) are depicted in the left panels. Tissues ipsilateral to
the injection site (i.e., tissues receiving projections originating in the
region of the lesion) are depicted in the right panels. All images were
focused at the level of the efferent vesicles in the vicinity of the inner
hair cell and auditory nerve fibers. A. Animal GP2-1, basal turn, 63X.
B. Animal CGL067, basal turn, 63X. C. Animal CGL067, third turn,
40X.D. Animal CGL067, apex, 40X. Arrows indicate specific regions
of interest. a. Medial efferent vesicles under outer hair cells. b. Inner
spiral bundle. c. Lateral efferent vesicles below the inner hair cells.
d. Tunnel crossing fibers. All scale bars = 50 lm.
FIG. 4. Surface area of synaptophysin immunolabeling in the
vicinity of the lateral efferent neurons was measured for cochlear
tissues ipsilateral (lesioned) and contralateral (control) to the brain
stem injection site. Quantification was conducted on tissues from
animal CGL067 (see Fig. 3); this animal was euthanized 1 week after
we injected melittin into the brain stem. Labeled area was measured
across a 325 lm region representative of labeling in each cochlear
turn. Each region selected for analysis was broken into four analysis
windows measuring approximately 81 lm in length (total analysis
window for each segment was 974 lm2). Average labeling within
each of the four 81 lm segments is depicted. We note that the
analysis region did not include inner spiral bundle or tunnel-crossing
fiber labeling.
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LSO that was not damaged by the melittin injection
in this animal, although we note that a precise ton-
otopic map of the guinea pig LSO is not available.
The reduction in synaptic labeling evident across the
other cochlear turns was not accompanied by gross
changes in the inner spiral bundle or the tunnel
crossing fibers. Labeling in the vicinity of outer hair
cells was unaffected, suggesting there was no disrup-
tion of the medial efferent neurons.
Electrophysiology
Threshold. Examples of typical CAP waveforms are
depicted in Figure 5. All scoring of CAP waveforms
was conducted by observers blind to experimental
condition. Threshold was defined as the lowest level
at which a CAP response could be identified by visual
inspection. CAP amplitude was typically 3–5 lV at
threshold. There were several animals for which CAP
amplitude, at 0-dB SPL, was greater than the 3–5 lV
criterion. Under these conditions, threshold was ar-
bitrarily scored as 0-dB SPL for summary purposes
because 0-dB SPL was the lowest level tested. CAP
thresholds were within the range of variation for
pigmented guinea pig CAP thresholds as reported
across different laboratories (e.g., Dum 1983; Thorne
and Gavin 1985; Fechter et al. 1992; Charlet de Sau-
vage et al. 1996; Mulheran and Harpur 1998).
FIG. 5. The sound-evoked whole-nerve compound action potential
(CAP) response of the auditory nerve is shown for a subset of the
levels tested (20, 40, 60, 80- dB SPL). Waveforms are in response to a
14-kHz acoustic signal (5 ms, see horizontal scale bar) and are from
a control animal (top) and an animal in which the lateral superior
olive (LSO) was lesioned (bottom). Data from the LSO-lesioned an-
imal were obtained on the seventh day postlesion. Vertical scale
bar = 170 lV.
FIG. 6. Threshold, defined as the lowest signal level (dB SPL) that
elicited a compound action potential (CAP) response, was deter-
mined for all animals. Top: Mean threshold (± SE) for acute elec-
trophysiology animals. All lesioned animal thresholds were
determined 1 week postlesion. Asterisks denote statistically reliable
differences between lesioned and unlesioned control animals (p’s <
0.05). Middle: Thresholds for chronic animal HIT1 were determined
before and 1 week after lesioning the lateral superior olive (LSO).
Bottom: Thresholds for chronic animals HIT2 and MISS1 were de-
termined at 10 kHz before and after the lesion surgery. Lesion-in-
duced change from prelesion threshold is depicted. Brain stem
sections from animal HIT2 exhibited targeted disruption of LSO;
brain stem sections from animal MISS1 showed no cytotoxin-in-
duced trauma. Postlesion assessment was conducted at time points
extending to 17 weeks.
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Threshold data from lesioned and control animals
(mean +/) standard error) tested in the acute pro-
cedure are summarized in Figure 6 (top). For each
test frequency, univariate ANOVAs were conducted
using SPSS version 10.1 (SPSS Inc., Chicago, IL).
Thresholds were significantly elevated in lesioned
animals at 2 kHz (F = 5.332, df = l, 11; p < 0.05). The
corresponding data from the chronic animals are
depicted in the lower panels of Figure 6 (middle:
HIT1; bottom: HIT2, MISS1). Both acute (top) and
chronic (middle, bottom) lesion groups showed a
tendency for threshold elevation at various frequen-
cies. Thresholds improved in only one case, that in
which the lesion did not damage LSO (MISS1).
N1 latency. N1 latency was compared across fre-
quency and intensity for lesion and control groups
using a three-way repeated-measures ANOVA in
which group was treated as a between-subject variable
and frequency and intensity were treated as within-
subject variables. There were no significant effects of
group, and no significant interactions for group ·
frequency or group · intensity. Statistical analyses
were first conducted on the latency data using the raw
data. These analyses were repeated using a fitted data
set in which missing (i.e., subthreshold) latency val-
ues were extrapolated from the existing data set. The
fitted data were derived using a 3-parameter model
where fit(x) = a0 * ln(x + a1) + a2. The use of this 3-
parameter model allowed for an excellent fit of the
data across the wide range of intensity and frequency
used in this study. No significant differences were
detected between raw and fitted data. However, the
fitted data set had the advantage of being a complete
FIG. 7. CAP amplitude, defined as the amplitude of the N1–P1
response component, was determined for all frequency/level com-
binations for acute electrophysiology test animals. The 20-kHz 100-
dB SPL data were discarded due to acoustic signal distortion at this
frequency/level combination. Mean CAP amplitude (± SE), averaged
within levels and across frequencies, is depicted. All lesioned ani-
mals were assessed 1 week postlesion. Top: CAP amplitude for
sound intensity levels measured in dB SPL. Asterisks denote statisti-
cally reliable pairwise differences between lesioned and unlesioned
control animals (p’s < 0.05). Diamonds denote differences that ap-
proached statistical reliability (p’s < 0.10). Bottom: CAP amplitude
for sound intensity levels normalized to account for differences in
threshold sensitivity. Intensity is expressed as dB sensation level (dB
SL, or, equivalently, dB above threshold). Because the overall sta-
tistical reliability of the lesion-induced change in CAP amplitude
was greater than 0.10, pairwise comparisons were not conducted.
FIG. 8. CAP amplitude, defined as the amplitude of the N1–P1
response component, was determined for all frequency/level com-
binations for animal HIT1 prior to and 1 week after melittin was
injected into the lateral superior olive (LSO). The 20- kHz 100-dB
SPL data were discarded due to acoustic signal distortion at this
frequency/level combination. CAP amplitude, averaged within levels
and across frequencies, is depicted. Top: CAP amplitude for sound
intensity levels measured in dB SPL. Bottom: CAP amplitude for
sound intensity levels normalized to account for differences in
threshold sensitivity. Intensity is expressed as dB sensation level (dB
SL, or, equivalently, dB above threshold).
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data set that was amenable to standard statistical
analyses for repeated measures with greater power
than was available with the raw data set that necessi-
tated a multiple pairwise comparisons approach.
Taken together, these data suggest the integrity of the
LSO had very little effect on N1 latency. Data from
our chronic animals were consistent with this obser-
vation. There was no evidence of lesion-induced dif-
ferences in latency of the CAP assessed prelesion and
postlesion.
CAP amplitude. The main effect of the LSO lesion
was a depression in CAP amplitude. This effect was
evident when responses were compared for equiva-
lent sound levels (dB SPL) as well as equivalent sen-
sation levels (dB SL). Moreover, lesion-induced
decreases in CAP amplitude were evident in both
acute (Fig. 7) and chronic (Fig. 8) test animals.
A three-way repeated-measures ANOVA was used
to compare control and lesioned animals across all
test frequency and level combinations. A main effect
of frequency was revealed, indicating that CAP am-
plitude was greater at the higher frequencies than at
the lower frequencies (F = 14.891, df = 9, 99; p <
0.001). This result was not surprising as CAP was as-
sessed at the round window. In addition, a group ·
intensity effect was revealed (F = 3.744, df = 20, 220; p
< 0.001), indicating that CAP amplitude in lesioned
animals was always smaller than CAP amplitude in
control animals but differences varied with intensity.
There were no significant interactions of group ·
frequency or group · frequency · intensity. This in-
dicated that the CAP amplitude depression in le-
sioned animals was consistent across frequency. We
therefore depict CAP amplitude averaged across fre-
quency for each intensity level.
The statistical reliability of lesion-induced changes
was analyzed first at equivalent sound pressure levels
(dB SPL) and then after sound levels were normal-
ized to threshold (dB SL). The amplitude of the CAP
sound-evoked response was smaller in lesioned ani-
mals than in control animals when expressed as dB
SPL (F = 4.547, df = 1, 11; p = 0.056). The statistical
reliability of the lesion-induced effect was reduced
(F = 1.789, df = 1, 11; p = 0.208) after normalizing for
sensation level. Therefore, pairwise comparisons were
conducted only for data expressed in dB SPL units.
There were no reliable group differences at 0–10 dB
SPL (p’s > 0.10); other within-level group compari-
sons revealed the depression in CAP amplitude in
lesioned animals was statistically reliable at 35-dB SPL
and 45–60-dB SPL (p’s < 0.05). The differences ap-
proached statistical reliability at all other levels in-
cluding 15-dB SPL and above (p’s < 0.10).
Lesioning the LSO similarly depressed CAP am-
plitude for animal HIT1, who was tested prelesion
and 1-week postlesion (Fig. 8, top: dB SPL; bottom:
dB SL). Animals HIT2 and MISS1 were repeatedly
tested at a single frequency (10 kHz) over a longer
time interval. HIT2 was unlike other LSO-lesioned
animals in that CAP amplitude was unchanged, rela-
tive to prelesion baseline, at 1–2 weeks postlesion.
Testing was not conducted at weeks 3 and 4; however,
by week 5, a very stable long-term (up to 17 week)
depression was evident in both raw (dB SPL) and
normalized (dB SL) responses. In contrast, CAP am-
plitude was not depressed in MISS1, the animal in
which LSO was intact after the melittin injection.
FIG. 9. Distortion product otoacoustic emissions (DPOAEs) show a
rapid adaptation shortly after signal onset when the medial efferent
pathway is intact. DPOAE adaptation is depicted for an unlesioned
control animal (top, CGL073) and HIT2 (middle); HIT2 underwent a
targeted disruption of the lateral superior olive (LSO). Variation in
amplitude of the adaptation component is consistent with unle-
sioned animals tested in this laboratory as well as other laboratories.
The ratio of levels of Fl and F2 were systematically varied across a
wide range for both animals. The amplitude of the adaptation across
level combinations is depicted in the bottom panel for animal HIT2.
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DPOAE adaptation. Adaptation of the DPOAE re-
sponse was assessed in all of the animals that received
chronic round window implants and lesions. Adap-
tation of the DPOAE response was evident in control
(Fig. 9, top) and LSO-lesioned animals (Fig. 9, mid-
dle). The amplitude of the adaptation was variable
across animals, which is consistent with observations
from other animals tested in this laboratory as well as
the variability described by Maison and Liberman
(2000). They classified animals with 10–25 dB of ad-
aptation as ‘‘strong MOC reflex’’ and animals with
less than 2 dB of adaptation as ‘‘weak MOC reflex.’’
DPOAE amplitude was carefully examined at
multiple level combinations for animal HIT2. As the
ratio of F1 and F2 levels was shifted, we observed a
change in the direction of adaptation as well as the
amplitude of adaptation (see Fig. 9, bottom). These
effects critically depend on the integrity of the cros-
sed medial olivocochlear neurons (Liberman et al.
1996; Kujawa and Liberman 2001). Taken together,
these results suggest that the medial efferent inner-
vation of the cochlea was relatively intact functionally,
at least in the animals for which DPOAE amplitude
was assessed.
DISCUSSION
The present results suggest that lateral efferent in-
nervation of the cochlea modulates auditory nerve
afferent output. After lesioning the LSO, CAP am-
plitude was clearly depressed. The effect was evident
when we compared lesioned and unlesioned animals
using an acute CAP assessment paradigm. The effect
was similarly striking when we compared prelesion
and postlesion data collected from the animals tested
in a chronic paradigm. Neither differences in N1 la-
tency nor overall changes in threshold sensitivity ac-
companied the compression of CAP amplitude.
Because there was a trend toward higher thresholds
in lesioned animals at some frequencies, however, we
adjusted the CAP amplitude data to account for any
differences in threshold sensitivity. After converting
to sensation level, the results were identical in that
CAP amplitude was depressed in lesioned animals
relative to control animals.
Disrupting the lateral efferent pathway could de-
press CAP if a relatively smaller population of audi-
tory nerve fibers were activated in the auditory system
that lacks (or has a reduced) lateral efferent inner-
vation. Alternatively, a lesion-induced breakdown in
the synchronization of single-unit firing could result
in smaller overall CAP amplitude. The present data
do not allow a distinction between these possibilities.
However, the lack of effect of the lesion on N1 latency
suggests that if there were a lesion-induced disruption
in synchronous firing, the effect was limited to a small
number of neurons. Gross disruption of synchronous
firing eliminates N1 (Goldstein and Kiang 1958). We
note that the possibility of the LSO lesion affecting
adapted neural firing rates (as shown by Zheng et al.
1999, after OCB transection) is not addressed by the
current data. Neural response adaptation (either
across the duration of the stimulus or across presen-
tations of multiple stimuli) does not occur for brief
acoustic stimuli separated by long inter-stimulus in-
tervals (such as those used in the current investiga-
tion; see Peake et al. 1962; Kiang et al. 1965).
Although we did not specifically include control
animals in which the skull was opened but melittin
was not injected, we did examine electrophysiological
data from two animals in which the lesion missed the
LSO. One of these animals was tested under the acute
test paradigm. Data from this animal (which are not
depicted) were indistinguishable from the control
animals that had not undergone the lesion surgery.
The second animal (MISS1) was tested in the chronic
test paradigm. Animal MISS1 was unlike the lesioned
animals in that(1) thresholds showed no increase
from prelesion baselines and (2) CAP amplitude
showed no postlesion depression. Thus, it is unlikely
that the differences reported here can be attributed
to uncontrolled consequences of the surgical proce-
dure. That is, the placement of the lesion within LSO
was critical in evoking the observed depression of
CAP amplitude.
The LSO is tonotopically organized such that
lower frequencies are represented more laterally.
Tonotopic distribution across LSO has been mapped
in gerbils (Sanes et al. 1989), rats (Sommer et al.
1993; Kelly et al. 1998), and cats (Tsuchitani and
Boudreau 1966; Guinan et al. 1972; Tsuchitani 1977).
Injections of dye into the base or apex of the guinea
pig cochlea produce labeling in LSO suggestive of a
similarly organized tonotopic map (see Stopp 1983;
Aschoff and Ostwald 1987; Robertson et al. 1987).
Based on the general tonotopic organization of LSO,
lower frequencies might be relatively more affected
than higher frequencies in the current experimental
animals because lesions predominantly affected the
lateral limb of the LSO. Such an effect was generally
evident in the current investigation [see Tables 1 (80-
dB SPL) and 2 (60-dB SPL)]. However, the lack of
statistically reliable interactions of group · frequency
or group · frequency · intensity indicate differences
across frequency were not statistically reliable. Taken
together, the lack of statistically different effects
across frequencies probably reflects the fact that the
medial limb was at least partially damaged in all le-
sioned subjects. Moreover, the medial limb was
completely lesioned for most subjects in a subset of
brain stem sections.
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Because frequency-specific effects presumably vary
based on the specific pattern of damage to the LSO in
each individual animal, we explored frequency effects
for HIT1, the only chronic animal tested at multiple
frequencies. The melittin injection into the brain
stem of this animal disrupted virtually all of the LSO
(see Fig. 10, top). Intact cell bodies were observed
only in the ventromedial region of the LSO. Postle-
sion CAP amplitude for HIT1 was most depressed
at our lower test frequencies (i.e., 4–10 kHz), some-
what less affected within the 12–16 kHz frequency
range (presumably corresponding to the intact cell
bodies within ventromedial LSO), and more de-
pressed at the highest test frequencies (i.e., 18–20
kHz). This effect is evident at the arbitrarily selected
levels presented in Tables 1 and 2, as well as across
levels as shown in subset of frequencies depicted in
Figure 10.
That the brain stem lesion targeted to LSO in fact
disrupted the lateral efferent innervation of the
cochlea is demonstrated by the reduction in synapt-
ophysin immunolabeling in the animals showing sy-
napse-specific labeling. With the exception of the
segment taken from the second turn of the cochlea in
one animal, synaptophysin-immunolabeling was re-
duced in the ear ipsilateral to the LSO lesion (com-
pared with the control ear contralateral to the
lesion). Thus, the LSO lesions decreased the inner-
vation of the auditory nerve dendrites by lateral ef-
ferent neurons. Of particular importance, we note
that the lesion in the brain stem of CGL067 was
centered in the lateral limb (i.e., the lower frequency
limb) of the LSO and only a small portion of ven-
tromedial LSO was intact after the injection of me-
littin. In the cochlea, synaptophysin immunolabeling
was most reduced in the upper turns, corresponding
to the lower-frequency regions (see Fig. 3, panels B–
D; Fig. 4). That labeling was intact in the second turn
of the cochlea may reflect innervation from ventro-
medial LSO, which was intact in some brain stem
sections. A frequency-specific correlation could not
be ascertained for GP2-1 (Fig. 3, panel A), as the
upper turns of the cochlea were damaged during
dissection of the tissue.
TABLE 1
Percent change in CAP amplitude at 80-dB SPL
Frequency (kHz)
2 4 6 8 10 12 14 16 18 20
Acutea )74 )53 )39 )46 )39 )45 )47 )48 )50 )39
HIT1b )54 )54 )58 )56 )56 )43 )55 )48 )58 )66
HIT2c )75
MISSIc,d )3
aPercent change calculated using 1-week postlesion guinea pig animals (n = 4) relative to intact controls (n = 9). Negative numbers indicate that lesioned guinea
pig CAP amplitude is smaller than that of intact controls.
bPercent change calculated using 1-week postlesion HIT1 animal data relative to prelesion within-subject control data. Negative numbers indicate CAP amplitude
was smaller at 1 week postlesion.
cPercent change calculated using 17-week postlesion HIT2 animal data relative to prelesion within-subject control data. Negative numbers indicate CAP
amplitude was smaller at the final 17-week postlesion time point.
dLSO intact.
TABLE 2
Percent change in CAP amplitude at 60-dB SPL
Frequency (kHz)
2 4 6 8 10 12 14 16 18 20
Acutea )87 )56 )37 )42 )41 )44 )54 )57 )53 )45
HIT1b )36 )56 )58 )53 )54 )46 )47 )50 )64 )64
HIT2c )83
MISSIc,d +54
aPercent change calculated using 1-week postlesion guinea pig animals (n = 4) relative to intact controls (n = 9). Negative numbers indicate lesioned guinea pig
CAP amplitude is smaller than that of intact controls.
bPercent change calculated using 1-week postlesion HIT1 animal data relative to prelesion within-subject control data. Negative numbers indicate CAP amplitude
was smaller at 1 week postlesion.
cPercent change calculated using 17-week postlesion HIT2 animal data relative to prelesion within-subject control data. Negative numbers indicate CAP
amplitude was smaller at the final 17-week postlesion time point.
dLSO intact.
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It is unlikely that disruption of the medial efferent
pathways resulted in the observed effects. First,
functional integrity of the medial efferent neurons
was verified empirically in the chronic test animals.
Specifically, DPOAE amplitude adaptation was meas-
ured as in the studies of Liberman and colleagues
(e.g., Liberman et al. 1996; Maison and Liberman
2000; Kujawa and Liberman 2001). While DPOAE
adaption revealed at least some functionally intact
medial efferent innervation of the cochlea, we note
that the data do not allow evaluation of subtle lesion-
induced changes in medial efferent function because
DPOAE adaptation was not assessed prelesion. Sec-
ond, integrity of the medial efferent neurons was
evaluated anatomically. For those brain stem sec-
tions stained with cresyl violet, the integrity of
the regions of the brain stem medial to LSO,
i.e., areas in which medial efferent neurons originate,
were assessed. This stain does not permit an as-
sessment of the integrity of the OCB, composed of
both medial and lateral efferent neurons traveling to
the cochlea, however. Thus, brain stem sections from
two animals were labeled using ACh-based histo-
chemical reactions to allow visualization of the OCB.
There was no evidence of damage to the OCB in
these animals (HIT2, MISS1). Finally, there was no
qualitative reduction in synaptophysin labeling under
the outer hair cells in the cochlear tissues that were
fixed with 4% paraformaldehyde. Thus, medial ef-
ferent projections to the cochlea did not appear to be
disrupted in any of the functional or morphological
analyses. Taken together, the evidence suggests the
observed lesion-induced depression in the sound-
evoked CAP was not a consequence of consistent
disruption to the medial efferent innervation of the
cochlea.
Our findings support and extend previous sug-
gestions that the lateral efferent innervation of the
cochlea modulates auditory nerve activity. Liberman
(1990) sectioned the OCB in cats and observed that
single auditory nerve fibers showed a significant
decrease in spontaneous activity. Although both me-
dial and lateral efferent pathways are disrupted by
sectioning the OCB, one explanation of the observed
changes in auditory nerve activity was that the intact
LOC system has a ‘‘net excitatory’’ effect (see Liber-
man 1990). De-efferentation-induced decreases in
spontaneous activity have since been observed in
chinchillas as well (Zheng et al. 1999). Finally, Groff
and Liberman (2002) recently presented preliminary
evidence that delivery of shock trains to the LSO
enhances the sound-evoked CAP response of the au-
ditory nerve. This enhancement of CAP amplitude
was observed only in the cochlea ipsilateral to the
stimulation site within the brain stem.
Both Liberman (1990) and Zheng et al. (1999)
have proposed a model in which lateral efferent in-
nervation of the cochlea produces a tonic, low-level
discharge of auditory nerve fibers (i.e., spontaneous
activity) which is reduced after de-efferentation. This
excitatory effect could be mediated through a
chronic release of neuroactive substances that directly
excite the afferent fibers. There are at least two
transmitter substances that, if eliminated from the
afferent synapse, could produce the spontaneous rate
depression described by Liberman (1990) and Zheng
et al. (1999), as well as the depression of the whole-
nerve response described in the current report. Spe-
cifically, disrupting a tonic release of either ACh or
dynorphin (dyn) from the lateral efferent neurons
FIG. 10. Top. Area of intact (undamaged) lateral superior olive
(LSO) was measured following injection of melittin into the vicinity
of LSO (e.g., ‘‘Lesioned’’) in the animal identified as HIT1. Control
comparisons were provided from measurements of LSO area in
contralateral, uninjected LSO (e.g., ‘‘Unlesioned’’). Section 1 was
the most caudal section in which LSO appeared. Sections were se-
quentially numbered until LSO was no longer evident. Bottom, left.
Amplitude of the compound action potential (CAP) response of the
auditory nerve is depicted across stimulus levels (dB SPL) at three
frequencies (6, 12, and 18 kHz). CAP was assessed prelesion using a
chronically implanted electrode, as well as 1 week postlesion. Right.
Percent change in CAP amplitude induced by the LSO lesion, at
frequencies corresponding to those depicted in the left panels.
Negative numbers represent a depression in CAP amplitude. Percent
change in CAP amplitude at other test frequencies is summarized for
a subset of stimulus intensities in Tables 1 and 2.
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could depress auditory nerve activity. Although nei-
ther tonic nor sound-induced release of ACh or dyn
from lateral efferent synapses has been empirically
verified, there are functional and anatomical data
supporting their ability to modulate the output of the
auditory nerve.
When applied in the vicinity of the auditory nerve
dendrites using microiontophoresis, ACh (0.5 M)
increases subsynaptic spiking and enhances gluta-
mate-induced auditory nerve activity (Felix and Eh-
renberger 1992). The prediction that CAP would be
depressed in the absence of lateral efferent release of
ACh is consistent with these results. This should be
interpreted with caution, however, as Bobbin and
Konishi (1971) reported that intracochlear perfusion
of ACh (250 lM) has no effect on CAP. Moreover, the
combination of ACh (250 lM) and eserine (10 lM), a
substance that blocks the metabolism of ACh, de-
pressed the amplitude of CAP. Murugasu and Russell
(1996) reported an elevation in CAP threshold when
ACh (100 lM) and physostigmine (20 lM), a sub-
stance that prevents the breakdown of ACh, were
perfused in the cochlea. Although Murugasu and
Russell (1996) did not report the effects of the ACh
perfusion on CAP amplitude, the threshold eleva-
tions they describe would likely be accompanied by a
level-dependent depression in CAP amplitude. It is
possible that the differences between the results of
Felix and Ehrenberger (1992) and those of Bobbin
and Konishi (1971) and Murugasu and Russell (1996)
are related to the different perfusion procedures.
Whereas Felix and Ehrenberger (1992) restricted
ACh delivery to the vicinity of the auditory nerve
dendrites, those investigators reporting inhibitory
effects of ACh (e.g., Bobbin and Konishi 1971;
Murugasu and Russell 1996) perfused the entire
cochlea with ACh. Perfusion of the entire cochlea
would result in stimulation of ACh receptors on the
OHCs as well as those on the auditory nerve dend-
rites.
A second putative lateral efferent neurotransmitter
that appears to have excitatory effects on afferent
activity is dynorphin. Chinchillas treated intrave-
nously with a dynorphin-like substance, ())pentazo-
cine, showed an enhancement of CAP amplitude and
improvement in threshold sensitivity (Sahley et al.
1991; Sahley and Nodar 1994). These excitatory ef-
fects were antagonized by intravenous naloxone
(Sahley et al. 1996b) and norbinaltorphimine applied
to the round window membrane of the cochlea
(Sahley et al. 1996a). The effects of dyn agonists on
whole-nerve potentials have not yet been evaluated
when dyn receptor agonists are infused directly into
the cochlea. In addition, the effects of dyn agonists
on single-unit auditory nerve activity remain to be
determined.
Perhaps the best-characterized putative lateral ef-
ferent neurotransmitter is dopamine (DA). DA is
postulated to mediate protection of the auditory
nerve dendrites against trauma-induced swelling
(Pujol et al. 1993; d’Aldin et al. 1995a, b), and also to
preserve threshold sensitivity after trauma (d’Aldin et
al. 1995a). This suggests that DA might ‘‘turn down’’
driven activity in the normal auditory system. During
infusion of DA agonists, auditory nerve single-unit
driven rates (Oestreicher et al. 1997; Ruel et al.
2001), the whole-nerve response (d’Aldin et al. 1995a,
b; Ruel et al. 2001), and spontaneous firing rates
[according to Ruel et al. (2001) but not Oestreicher
et al. (l997)] are in fact decreased. Taken together,
DA consistently depresses auditory nerve responses.
DA appears to reduce auditory nerve activity, but
each of the past de-efferentation investigations (e.g.,
Liberman 1990; Zheng et al. 1999), as well as the
current LSO lesion experiment, supports a net exci-
tatory effect of lateral efferent innervation of the
cochlea. That is, auditory nerve activity has been de-
pressed in the absence of lateral efferent innervation.
Thus, it initially seems that DA is not a primary de-
terminant of auditory nerve activity. Although more
speculative, we acknowledge there is at least one
mechanism through which disruption of DA release
by the lateral efferent neurons in the cochlea could
result in a depression of CAP amplitude, as shown in
the current findings. When DA receptors in the
cochlea are blocked with the D1 receptor antagonist
eticlopride or the D2 receptor antagonist SCH-23390,
high-spontaneous-rate auditory nerve fibers show a
transient increase in spontaneous rate followed by a
depression in rate (Ruel et al. 2001). At least the
eticlopride-induced depression in rate is accompa-
nied by auditory nerve dendritic swelling (Ruel et al.
2001). If lack of D2 receptor activation underlies
dendritic swelling and a related suppression of neural
activity, then a lesion that reduces or eliminates the
endogenous supply of DA might similarly result in
dendritic swelling and depressed auditory nerve ac-
tivity. Swelling following de-efferentation has been
reported in monkeys (Bodian and Gucer 1980) and
rats (Spangler and Warr 1987) but not cats (Liber-
man 1990).
In summary, our data show that the gross sound-
evoked auditory nerve potential, the CAP, is de-
pressed following disruption of the lateral efferent
pathway. These data support the suggestion that de-
pressed single-unit auditory nerve activity after tran-
section of the medial and lateral auditory efferent
pathways is a consequence of lateral efferent de-in-
nervation (e.g., Liberman 1990; Zheng et al. 1999). In
the current investigation, the medial efferent inner-
vation of the cochlea appeared to be functionally
intact, at least in the animals in which we assessed
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DPOAE amplitude, and there was no morphological
evidence of disruption to medial efferent neurons.
Given the recent demonstration that electrical stim-
ulation of cell bodies originating in the LSO en-
hances sound-evoked auditory nerve response (Groff
and Liberman 2002), the data provide compelling
evidence that lateral efferent neurons modulate au-
ditory nerve activity that occurs spontaneously and as
a result of acoustic stimulation.
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